• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Premarket Approval (PMA)

  • Print
  • Share
  • E-mail
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC

New Search Back to Search Results
Note: this medical device record is a supplement. The device description may have changed. Be sure to look at the original PMA to get an up-to-date view of this device.
Classification Nameimmunohistochemistry antibody assay, c-kit
Generic Nameimmunohistochemistry antibody assay, c-kit
Regulation Number864.1860
6392 via real
carpinteria, CA 93013
PMA NumberP040011
Supplement NumberS002
Date Received10/16/2012
Decision Date11/02/2012
Product Code
NKF[ Registered Establishments with NKF ]
Advisory Committee Pathology
Supplement Typenormal 180 day track no user fee
Supplement Reason labeling change - indications/instructions/shelf life/tradename
Expedited Review Granted? No
Combination Product No
Approval Order Statement 
Approval for changing the company prefix to the device name (from dakocytomation c-kit pharmdx to c-kit pharmdx). The device, as modified, will be marketed under the trade name c-kit pharmdx.